PMID: 13761605May 1, 1961Paper

Comparison of dissolution and absorption rates of different commercial aspirin tablets

Journal of Pharmaceutical Sciences
G LEVY

Abstract

No abstract listed.

References

Sep 1, 1960·Clinica Chimica Acta; International Journal of Clinical Chemistry·D WATSON
Sep 1, 1960·Royal Society of Health Journal·D WATSON
Jul 18, 1946·The New England Journal of Medicine·G LOLLI, R SMITH

❮ Previous
Next ❯

Citations

Jul 1, 1975·Journal of Clinical Pharmacology·G Levy, A Yacobi
Jan 1, 1968·The American Journal of Digestive Diseases·R H Salter
Oct 26, 2007·Archives of Pharmacal Research·Omran M O Alhamami
Jul 14, 2005·European Journal of Drug Metabolism and Pharmacokinetics·Jean-Marc Aiache
Jan 1, 1963·The Journal of Pharmacy and Pharmacology·A J CUMMINGSL F WIGGINS
Nov 1, 1967·The Journal of Pharmacy and Pharmacology·A G Mitchell, D J Saville
Nov 1, 1969·The Journal of Pharmacy and Pharmacology·K Marshall, D B Brook
May 1, 1969·The Journal of Pharmacy and Pharmacology·P H Elworthy, F J Lipscomb
Apr 1, 1996·The Journal of Pharmacy and Pharmacology·I M Ouriemchi, J M Vergnaud
Jan 8, 1972·British Medical Journal·S S Davis
Feb 1, 1976·Postgraduate Medical Journal·R M RowanD F Brown
Jun 14, 2008·Pharmaceutical Research·Vangelis KaralisVinod P Shah
Jan 1, 1993·European Journal of Drug Metabolism and Pharmacokinetics·J P Skelly, G F Shiu
Apr 1, 1987·Journal of Microencapsulation·Y V PathakA K Dorle
Apr 1, 1990·Journal of Microencapsulation·Y V Pathak, A K Dorle
Apr 1, 1989·Journal of Microencapsulation·Y V Pathak, A K Dorle
Dec 29, 2006·Drug Development and Industrial Pharmacy·Mohammad Barzegar-Jalali, Siavoush Dastmalchi
Dec 2, 2010·Expert Opinion on Drug Metabolism & Toxicology·Vangelis KaralisPanos Macheras
Jan 1, 1977·Journal of Pharmaceutical Sciences·S M BergeD C Monkhouse
Jun 8, 2012·Journal of Pharmaceutical Sciences·Jennifer B DressmanMarkus Zimmer
Jun 1, 1992·Journal of Pharmaceutical Sciences·V P ShahJ P Skelly
Apr 10, 2013·Journal of Pharmaceutical Sciences·Panos MacherasGeorgia Valsami
May 7, 2010·Journal of Veterinary Pharmacology and Therapeutics·Z ZhaoX Meng
Nov 1, 1976·Survey of Ophthalmology·J S Mindel
Sep 1, 1980·British Journal of Clinical Pharmacology·H SeveliusS S Bloomfield
Sep 26, 2015·Journal of Pharmacokinetics and Pharmacodynamics·Ho-Leung Fung, William J Jusko
Oct 1, 1985·Journal of Pharmacokinetics and Biopharmaceutics·L J LeesonN Chiang
Oct 1, 1970·Journal of Pharmaceutical Sciences·B J McGeeG C Walker
Nov 1, 1972·Journal of Pharmaceutical Sciences·W Lowenthal
Oct 31, 2018·Clinical Pharmacology and Therapeutics·Corinne Seng YueMurray P Ducharme
Jan 1, 1970·Irish Journal of Medical Science·O I Corrigan, R F Timoney
Feb 1, 1974·Postgraduate Medical Journal·H L Currey
Apr 1, 1994·The Annals of Pharmacotherapy·J E Watson, E T Tagupa
Nov 1, 1968·Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft·R Hüttenrauch, I Keiner
Jul 2, 2021·Advanced Science·Rodolfo Mundaca-UribeJoseph Wang
Aug 1, 1969·Journal of Pharmaceutical Sciences·J Haleblian, W McCrone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.